Ocaratuzumab: A New Hope for Autoimmune Diseases? A innovative therapeutic, ocaratuzumab, seems to offer promising outcomes for people suffering with multiple autoimmune conditions. Scientists suggest that its distinct mechanism of action, modulating certain key group of B cells, might

Etaracizumab, formerly known as MEDI523 and subsequently LM609, represents a promising approach in immune therapy. This monoclonal antibody is built to precisely block the activity of C1q, a essential component of the complement system involved in tissue damage. Studies have explored its therape